| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $411.2M | -1.4% |
| Cost of Revenue | $285.6M | -9.7% |
| Gross Profit | $125.6M | +24.8% |
| R&D Expense | $139.3M | -1.4% |
| SG&A Expense | $95.7M | +17.5% |
| Operating Income | -$210.1M | +16.9% |
| Interest Expense | $23.9M | -3.2% |
| Pre-tax Income | -$216.1M | +20.7% |
| Income Tax | $4.0M | -7.4% |
| Net Income | -$220.2M | +20.5% |
| EPS (Basic) | -$9.41 | -1370.3% |
| EPS (Diluted) | -$9.41 | -1370.3% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $141.6M | -37.0% |
| Accounts Receivable | $86.1M | -10.2% |
| Inventory | $214.9M | +2.7% |
| Current Assets | $462.0M | -18.5% |
| Total Assets | $792.2M | -11.8% |
| Current Liabilities | $383.6M | +30.6% |
| Long-term Debt | $228.5M | -23.1% |
| Total Liabilities |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$62.8M | +57.2% |
| Capital Expenditures | $4.2M | -65.5% |
| Investing Cash Flow | -$4.2M | +65.5% |
| Financing Cash Flow | -$20.0M | -170.1% |
| Free Cash Flow | -$67.0M | +57.9% |
| $770.9M |
| +1.3% |
| Stockholders' Equity | $21.3M | -84.5% |